Search
Alpha Tau Medical Ltd
DRTSAdd to Watchlist
14.360USD
-0.160-1.10%
Market hours 09/24, 11:50（ET）
1.30BMarket Cap
LossP/E TTM
Alpha Tau Medical Ltd (DRTS) Stock Price Target & Forecast
Analyst Rating
Based on 5 analysts giving stock ratings to Alpha Tau Medical Ltd in the past month.
Buy
2 Strong Buy
2 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
17.800USD+17.57%
DRTS Analyst Recommendation Trends
In the current month, DRTS has received 2 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. DRTS average Analyst price target in the last month is 17.800.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
2
2
2
2
2
2
2
2
2
2
1
1
2
2
2
2
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
5
4
4
4
4
4
4
Financial Forecasting
Based on analysts' estimates, DRTS EPS is projected to reach -0.147 in FY2026Q3, following reported EPS of -0.504 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.12
-0.12
-0.14
-0.15
-0.15
Actual
-0.14
-0.26
-0.50
--
--
Surprise
-14.05%
-107.05%
-257.23%
--
--
FAQs
What is Alpha Tau Medical Ltd's price target?
Analysts forecast that Alpha Tau Medical Ltd's price target is USD 8.50, with the highest forecast at USD 12.00 and the lowest forecast at USD 5.00.
How have Alpha Tau Medical LtdDRTS's recent earnings per share performed?
The market expectation was USD -0.50, while Alpha Tau Medical LtdDRTS's earnings per share (EPS) for the previous quarter was USD -0.26. EPS for the next quarter is expected at USD -0.15.
What is the analyst rating for Alpha Tau Medical Ltd?
Based on the ratings of Alpha Tau Medical Ltd's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.